CLINICAL RECOMMENDATIONS |
|
Becattini С., Kokorin V.A., Lesniak W., Marin-Leon I., Medrano F.J., Morbidoni L., Marra A.M., Biskup E., Riera-Mestre A., Dicker D.
Pulmonary embolism – An EFIM guideline critical appraisal and adaptation for practicing clinicians
|
7-20 |
ORIGINAL STUDIES |
|
Kobzeva N.D., Martynov A.I., Terentiev V.P.
Ways to optimize the prediction of fatal and non-fatal cases of stroke in patients with peripheral atherosclerosis
|
21-27 |
|
Izmozherova N.V., Popov A.A., Shambatov M.A., Baksheev I.Yu.
Smell and taste impairment in young adults with COVID-19
|
28-34 |
REVIEWS |
|
Bolieva L.Z., Adasheva T.V., Malyavin A.G., Bichenova E.R., Daurova M.D.
Obstructive sleep apnea and chronic heart failure
|
35-43 |
|
Shishkova V.N., Ustarbekova D.B., Shishkov V.A., Imamgayazova K.E., Kapustina L.A.
Psycho-emotional disorders in chronic heart failure patients
|
44-49 |
|
Alieva A.M., Teplova N.V., Reznik E.V., Valiev R.K., Rakhaev A.M., Kudaeva M.V., Akhmatov I.Z., Arakelyan R.A., Nikitin I.G.
Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases
|
50-59 |
|
Alieva A.M., Teplova N.V., Kislyakov V.A., Voronkova K.V., Shnakhova L.M., Valiev R.K., Rakhaev A.M., Elmurzaeva D.A., Malkarova D.S., Nikitin I.G.
Biomarkers in cardiology: microRNA and heart failure
|
60-70 |
|
Bakulin I.G., Skalinskaya M.I., Skazyvaeva E.V., Rasmagina I.A., Zhuravleva M.S., Usachev R.A.
Extraintestinal manifestations of inflammatory bowel diseases: modern conception and contribution to the disease insight
|
71-93 |
|
Korneeva N.V.
Arterial hypertension and smoking: what a therapist should know
|
94-101 |
GUIDELINES FOR PRACTITIONERS |
|
Vladimirova N.N., Myasnikova E.V., Beketova T.V., Peredelkina A.I., Shunaev V.M., Pikunova I.N.
A case of diagnostics of IgG4-related disease with primary renal damage and secondary arterial hypertension
|
102-109 |
|
Grigorieva E.V., Bogdalova L.R.
SARS-CoV-2 infection in the patient with kidney transplant
|
110-113 |
LECTURE |
|
Boeva O.I., Kokorin V.A.
Alirocumab in patients of very high cardiovascular risk
|
114-122 |
|
Larina V.N., Larin V.G.
The place of bisoprolol cardioselective beta-adrenoblocker in treatment of patients with different chronic heart failure phenotypes
|
123-132 |
|
Emelyanov A.V., Leshenkova E.V., Sergeeva G.R., Tsukanova I.V.
Modern treatment of bronchial asthma
|
133-141 |
|
Borisov V.V.
Importance of diagnostics and therapy of COVID neuroinfection urological complications for internal medicine
|
142-151 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
|
Interaction between rivaroxaban and apixaban intake and major ischemic and hemorrhagic events occurrence in patients with atrial fibrillation: a retrospective cohort study from real clinical practice
|
152-153 |
|
Zakharov V.V., Gromova D.O.
Neurological manifestations of post-covid syndrome
|
154-161 |
|
Boeva O.I., Kokorin V.A., Khripunova A.A.
Combined hypolipidemic therapy for mixed atherogenic dyslipidemia: review
|
162-173 |
|
Larina V.N.
Treatment of arterial hypertension in high risk comorbid patients: possibilities of amlodipine and losartan combination
|
174-181 |
Guideline for practitioners |
|
Zadionchenko V.S.
«Therapist’s handbook. Rational pharmacotherapy» (guidance for practicing physicians, 2nd edition, chief editors – acad. of the RAS Martynov A.I., prof. Larina V.N.; Moscow: Litterra, 2021)
|
182 |
|
Voevoda M.I.
«Diagnosis and treatment of a new coronaviral infection. Organization of work in multidisciplinary hospital conditions» (guidance for doctors ed. by Vechorko V.I.; Moscow: Praktika, 2020)
|
183 |
|
Oslopov V.N.
«Rare and interesting clinical cases in the practice of an internist» (ed. by prof. Sayfutdinov R.G.; Moscow: GEOTAR-Media, 2020)
|
184 |
Activities of RNMOT |
|
Report on the activities of the Russian Scientific Medical Society of Internal Medicine (RSMSIM) in 2021
|
185-188 |
Русский
